long-term effects of semaglutide GLP-1 drugs such as and tirzepatide are transforming obesity and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights GLP-1 Side Effects and Semaglutide:

Research, including recent findings from the SELECT trial, indicates that GLP-1 agonists like semaglutide can significantly reduce the risk of major cardiovascular events, such as heart attacks and strokes, especially in individuals with obesity but without diabetes

Some patients experience a brief period of increased appetite during the transition

They are not FDA-approved for human or animal consumption, and Purerawz does not sell these compounds for use in humans or animals

Like injectable GLP-1s, it helps regulate appetite, metabolic function, and insulin signaling

Click here to explore more

Module 6 Long-Term Support and Maintenance Help clients transition off medications and build long-term healthy habits